Vinva Investment Management Ltd
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1968109
SYDNEY, C3
Position in BCRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$383,855
+$237,738 QoQ
Shares Held
40,321
+115.2% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Vinva Investment Management Ltd holds $108,435,653 across 5 Drug Manufacturers - Specialty & Generic names.
All Filings in BCRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $383,855 | 40,321 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $146,117 | 18,733 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $402,732 | 53,061 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $477,818 | 53,328 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||